Skip to content

A study in adults testing a Unani formulation Habb and Tila to evaluate its safety and effectiveness in treating Bars (Vitiligo)

A Randomized Controlled Clinical Trial Comparing the Safety and Efficacy of Unani Formulation Habb and Tila with Oral and Topical Methoxsalen in the Management of Bars (Vitiligo) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100792
Enrollment
50
Registered
2026-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Oral- Habb, Topical- Tila : HABB: Ajmud/Karafs (Apium graveolens Linn), Babchi (Psoralea corylifolia Linn), Tukhm e panwar (Cassia tora Linn), Kanwal gatta (Nelumbo nucifera Gaertn).

Sponsors

Government Nizamia Tibbi College and General Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18-60 years. Subjects of Non-segmental vitiligo of either gender. Non-segmental vitiligo with chronicity of less than 3 years. Patients with less than 5 new lesions in the last month. Site of lesion: scalp, face, extremities, trunk and genitalia.

Exclusion criteria

Exclusion criteria: Segmental vitiligo / Universal vitiligo / Vitiligo with leukotrichia. Pregnant and lactating women. History of photosensitivity (or) other skin diseases. History of Diabetes Mellitus. Significant pulmonary (or) cardiovascular (or) hepatorenal dysfunction. Known cases of Immuno-compromised condition (HIV/AIDS) and Malignancy.

Design outcomes

Primary

MeasureTime frame
Change in Vitiligo Area Scoring Index (VASI) Reduction in Vitiligo Disease Activity (VIDA) Score Timepoint: 0,2,4,6,8,10,12,14 and 16 weeks

Secondary

MeasureTime frame
Improvement in quality of life on Vit-Qol (Assessment of Patient s Quality of Life) Timepoint: 0 and 16 weeks

Countries

India

Contacts

Public ContactDr Bushra Fathima Nuha

Government Nizamia Tibbi College and General Hospital

ahmedfarhath66@gmail.com9848195067

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026